Search Results 1181-1190 of 17583 for corticosteroid

  1. Study of M5049 in DM and PM Participants (NEPTUNIA) - Mayo Clinic

    * Stable doses of oral corticosteroids (CS) and/or maximum of 1 non-corticosteroid immunosuppressive/immunomodulatory medications (methotrexate, 6 ...

  2. TruGraf® Long-term Clinical Outcomes Study

    ... corticosteroids was associated with improved outcomes in these patients. Seventy-two patients, stratified by donor source, were randomized to biopsies at 1 ...

  3. Lichen planus - Symptoms and causes - Mayo Clinic

    Topical corticosteroids: Use and adverse effects. https://www.uptodate.com/contents/search. Accessed Nov. 21, 2022. Zubair R, et al. What's new in ...

  4. A Study of Pembrolizumab Alone or Combined with CC-486 for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer - Mayo Clinic

    ... corticosteroids or immunosuppressive drugs) ... Replacement therapy (e.g. thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or ...

  5. Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung - Mayo Clinic

    corticosteroids - No occurrence of acute exacerbations of the underlying condition requiring psoralen plus ultraviolet A radiation, methotrexate, retinoids ...

  6. Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or CCUS - Mayo Clinic

    ... corticosteroids (any dose) may continue therapy up until the new regimen has started at investigator discretion; corticosteroids can be tapered to lowest ...

  7. A Study of Using Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma - Mayo Clinic

    Participation eligibility · Patients requiring corticosteroids who have not been on a stable or decreasing dose of corticosteroid for the 7 days prior to ...

  8. New COPD guidelines from international panel provide updated recommendations

    If you have frequent exacerbations (chest colds), treatment with inhaled corticosteroids, combination inhalers, or long-acting bronchodilators can reduce their ...

  9. AMG 181 in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

    corticosteroids (non-US sites only). Neurological exam free of clinically significant, unexplained signs or symptoms during screening and no clinically ...

  10. A Study of SGN-B7H4V in Advanced Solid Tumors - Mayo Clinic

    - and are off corticosteroids prescribed for symptoms associated with brain metastases for at least 7 days prior to the first dose of study treatment ...